USPTO Examiner SHAH NILAY J - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19351989SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICEOctober 2025January 2026Allow300YesNo
19223340INTRANASAL AND OLFACTORY DELIVERY DEVICES AND METHODS OF USEMay 2025December 2025Allow720YesNo
19192037ORAL DRUG DELIVERY DEVICE WITH COVER RELEASEApril 2025October 2025Allow510YesNo
19038367INTRANASAL AND OLFACTORY DELIVERY DEVICES AND METHODS OF USEJanuary 2025May 2025Allow310NoNo
19029194DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025July 2025Allow610YesNo
19028589DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025June 2025Allow510YesNo
19028358DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025May 2025Allow410YesNo
19028997DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025July 2025Allow610YesNo
19028896DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025June 2025Allow510YesNo
19002415APPLICATOR AND MICRONEEDLE ARRAY PATCH DELIVERY SYSTEMDecember 2024January 2026Allow1221YesNo
19002468APPLICATOR FOR A MICRONEEDLE ARRAY PATCH DELIVERY SYSTEMDecember 2024June 2025Allow510YesNo
18764716MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USEJuly 2024April 2025Allow1020YesNo
18532090METHODS OF PREPARING BALLOON EXPANDABLE CATHETERS FOR CARDIAC AND VASCULAR INTERVENTIONSDecember 2023February 2026Allow2710NoNo
18387405TRANS MIDDLE EAR-INNER EAR FLUID FLOW IMPLEMENTATIONSNovember 2023March 2026Abandon2841NoNo
18370312SEPTUM HOUSINGSeptember 2023February 2026Allow2911YesNo
18469448MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USESeptember 2023January 2026Allow2810NoNo
18368722BALLOON CATHETER WITH FORTIFIED PROXIMAL INFUSION OUTLET PORT, AND MANUFACTURING THEREOFSeptember 2023September 2025Allow2410NoNo
18239646PRESSURE ACTUATED FLOW CONTROL DEVICE FOR GRAVITY IV SETSAugust 2023March 2025Allow1910YesNo
18224395METHOD AND DEVICE FOR ENHANCED COMPOSITION DELIVERYJuly 2023April 2024Allow910NoNo
18352824ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAMEJuly 2023July 2025Abandon2420YesNo
18339142INFUSION LIQUID HEATING AND FLOW-VELOCITY-MONITORING SYSTEM FOR CLINICAL USEJune 2023February 2026Allow3200YesNo
18325985ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAMEMay 2023January 2024Allow810YesNo
18199747SYRINGE PUMPMay 2023June 2025Allow2510NoNo
18305560SUCTION DEVICE FOR SUCKING OBSTRUCTION IN RESPIRATORY TRACT AND USE METHOD THEREFORApril 2023March 2026Allow3520NoNo
18192581DRUG DELIVERY DEVICE AND METHOD OF OPERATIONMarch 2023November 2025Abandon3240YesNo
18125254Angiogram Injections Using Electrocardiographic SynchronizationMarch 2023October 2025Allow3010YesNo
18111765Process for Delivery of Viscous Drug TherapiesFebruary 2023July 2025Allow2911YesNo
18108449INTEGRATED VASCULAR DELIVERY SYSTEMFebruary 2023July 2025Allow2910YesNo
18106850AUTOMATIC BREAST PUMP DEVICEFebruary 2023March 2026Allow3710YesNo
18104344Trigger Arrangement for an Infusion DeviceFebruary 2023November 2025Allow3320NoNo
18087944Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety DeviceDecember 2022January 2026Allow3710NoNo
18083897Drug Delivery Device with a CapDecember 2022September 2025Allow3310NoNo
17989367PRECISION STEERABLE AND ANGLED MEDICATION DELIVERY SYSTEMNovember 2022October 2025Allow3510YesNo
17956420INJECTOR DEVICESeptember 2022September 2024Allow2400NoNo
17935306DEVICE FOR MONITORING AND TREATING BRADYARRHYTHMIASeptember 2022February 2023Allow510YesNo
17902329Selectively Controlling Fluid Flow Through a Fluid PathwaySeptember 2022July 2025Allow3420YesNo
17901049Instrument Delivery Device with Nested HousingSeptember 2022December 2025Allow3910YesNo
17896452AUTO-INJECTOR WITH ACTIVE AGENT CONTAINER LATCHINGAugust 2022December 2024Allow2810YesNo
17893066WIRELESS PATCH SYSTEM FOR TRANSDERMAL, TRANSMUCOSAL AND DENTAL ELECTRICAL DRUG DELIVERYAugust 2022October 2025Allow3810NoNo
17820385ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAMEAugust 2022June 2023Allow1010YesNo
17889318EAR CANAL MEDICATION APPLICATORAugust 2022February 2026Abandon4201NoNo
17886137PREFILLED SYRINGE INJECTORAugust 2022November 2025Allow3910YesNo
17883302SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYEAugust 2022June 2025Allow3410YesNo
17797657IMPROVED INJECTION DEVICEAugust 2022October 2025Allow3810NoNo
17759434SYSTEMS AND METHODS FOR A CATHETER STABILIZATION AND OCCLUDER APPARATUSJuly 2022January 2026Allow4111YesNo
17868600SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTSJuly 2022May 2025Allow3410YesNo
17867224Priming System for Infusion DevicesJuly 2022April 2025Allow3310YesNo
17758903A MEDICAL DEVICEJuly 2022April 2025Allow3310YesNo
17792510ACTIVATION DEVICE AND ODOR REMOVAL DEVICE INCLUDING SAMEJuly 2022March 2026Allow4410NoNo
17791725MICRONEEDLE APPLICATORJuly 2022January 2026Abandon4201NoNo
17855857Delivery System And Method For Delivering Material To A Target Site During A Medical ProcedureJuly 2022June 2025Allow3620YesNo
17844415DOSE SETTING MECHANISM AND METHOD OF LOCKING AN INJECTION PENJune 2022February 2026Abandon4410NoNo
17807736EXTERNAL CATHETER STABILIZERJune 2022April 2025Allow3411NoNo
17843358WIRE DELIVERY DEVICE, AND DRUG SOLUTION INJECTION DEVICEJune 2022January 2026Abandon4310NoNo
17664546DEVICE, SYSTEM, AND METHOD FOR APPLYING A PHARMACEUTICAL FLUIDMay 2022January 2026Allow4410YesNo
17749265Systems and Methods for Precision or Personal Pharmaceutical DosingMay 2022April 2025Allow3410YesNo
17740153MONITORING UPSTREAM FLOW CHARACTERISTICS FOR A PUMPMay 2022March 2025Allow3510YesNo
17774932ASSEMBLY, CASSETTE AND MEDICAMENT DELIVERY DEVICEMay 2022July 2025Allow3910YesNo
17737270FLUID DELIVERY APPARATUS HAVING A CONTROLLER ASSEMBLY AND METHOD OF USEMay 2022March 2026Allow4610NoNo
17661387Guidewire Retraction DeviceApril 2022April 2023Allow1220YesNo
17720175SYSTEMS AND METHODS TO AUTOMATICALLY ADMINISTER A PSYCHOACTIVE SUBSTANCE TO AN AIRWAY OF A USER BASED ON A DETECTED EVENT OR CONDITIONApril 2022January 2023Allow920YesNo
17719418SYRINGE WITH FLEXIBLE RESERVOIR AND METHOD OF USEApril 2022August 2023Abandon1620NoNo
17767330INTRAURETHRAL MEDICATION DOSAGE FORM AND DEVICEApril 2022February 2026Allow4720YesNo
17715891PRESSURE-REGULATING CONNECTOR FOR INFUSIONApril 2022February 2025Allow3510YesNo
17715047CONNECTOR ADAPTED TO ATTACH AN IRRIGATION CATHETER TO TUBING OF AN ANAL OR STOMAL IRRIGATION SYSTEMApril 2022April 2025Allow3710YesNo
17754556ATRAUMATIC REMOVABLE CELL ENCAPSULATION DEVICESApril 2022July 2025Allow3911NoNo
17707863RADIOACTIVE CONDUIT AND METHOD FOR IN VIVO TREATMENT OF TUMORSMarch 2022December 2023Allow2121YesNo
17706708IV FLOW REGULATORMarch 2022March 2025Allow3510YesNo
17656531DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODSMarch 2022May 2025Allow3811YesNo
17655900DEVICE AND METHOD FOR MONITORING AND TREATING ADVANCED BRADYCARDIAMarch 2022June 2022Allow310YesNo
17701439LAMPREY LOCK DEVICEMarch 2022September 2022Allow610YesNo
17685389NASAL ASPIRATOR CAPABLE OF EFFECTIVELY PREVENTING BACKFLOW AND CONTROL METHOD THEREOFMarch 2022August 2022Allow510NoNo
17639641PATIENT LINE AIR DETECTION AND REUSE PREVENTIONMarch 2022January 2025Allow3510YesNo
17673227MICRONEEDLE ASSEMBLYFebruary 2022October 2025Allow4410YesNo
17669918Adjustable Medium DiverterFebruary 2022May 2025Abandon4010NoNo
17590175INJECTOR AND METHOD OF ASSEMBLYFebruary 2022February 2025Allow3710YesNo
17588228MINIMALLY TRAUMATIC TROCAR METHOD FOR SUBCUTANEOUS MEDICATION DELIVERYJanuary 2022December 2025Allow4610YesNo
17645503MICRONEEDLE ARRAYS AND METHODS OF MAKING AND USINGDecember 2021February 2026Abandon5020NoNo
17558577METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCERDecember 2021October 2022Allow1020YesNo
17549974Systems and Methods for Guidewire RetractionDecember 2021May 2022Allow510YesNo
17617052ELECTRONICALLY-CONTROLLED CAPTURING SYSTEM FOR DRUG DELIVERY SYSTEMSDecember 2021July 2025Allow4410NoNo
17518044ELECTROCHEMICAL PUMP UNIT OF MESH COMBINED ELECTRODENovember 2021February 2025Allow4010YesNo
17512040SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICEOctober 2021January 2026Allow5140YesNo
17498525EVENT CAPTURE DEVICE FOR MEDICATION DELIVERY INSTRUMENTSOctober 2021January 2025Allow3910YesNo
17493118VOLUME MONITORING SYSTEMSOctober 2021March 2025Abandon4110NoNo
17489620SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEM WITH VARYING RATESSeptember 2021February 2025Allow4111YesNo
17489625SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEMSeptember 2021February 2025Allow4111YesNo
17448618SURGICAL HUMIDIFIER CONTROLSeptember 2021January 2025Allow4010YesNo
17482715MEDICAL DEVICE INCLUDING SHAFT WITH FLAT WIRE COILSeptember 2021September 2025Allow4720YesNo
17476426MEDICAL DEVICE AND METHOD FOR LIMITING THE USE OF THE MEDICAL DEVICESeptember 2021June 2022Allow920YesNo
17462130DRUG DELIVERY VIA MECHANICAL VIBRATION BALLOONAugust 2021September 2024Allow3710YesNo
17406760MEDIUM INJECTION DIVERSION AND MEASUREMENTAugust 2021January 2025Abandon4110NoNo
17405656INTRAVENOUS CATHETER DEVICE WITH INTEGRATED EXTENSION TUBEAugust 2021September 2024Allow3710YesNo
17398370SYSTEMS AND METHODS FOR CONTROLLED DELIVERY OF ANALGESIC AND HYPNOTIC AGENTSAugust 2021April 2025Allow4410YesNo
17393187SUCTION DEVICE FOR SUCKING OBSTRUCTION IN RESPIRATORY TRACT AND USE METHOD THEREFORAugust 2021March 2023Allow1930YesNo
17425539DETACHABLE-TIP BALLOON MICROCATHETER FOR EMBOLIZATION OF VASCULAR PATHOLOGYJuly 2021October 2025Allow5111NoNo
17355061Medicament Delivery Device with Rotator Retaining the Plunger RodJune 2021September 2024Allow3810NoNo
17350883INJECTOR AND METHOD OF ASSEMBLYJune 2021November 2021Allow500YesNo
17335996Intravenous Fluid Delivery System and ApparatusJune 2021August 2023Allow2751YesNo
17244898RETRACTABLE NEEDLE CATHETER DELIVERY APPARATUSApril 2021October 2021Allow610YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SHAH, NILAY J.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
6
(75.0%)
Examiner Reversed
2
(25.0%)
Reversal Percentile
41.8%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
5
(20.0%)
Not Allowed After Appeal Filing
20
(80.0%)
Filing Benefit Percentile
26.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SHAH, NILAY J - Prosecution Strategy Guide

Executive Summary

Examiner SHAH, NILAY J works in Art Unit 3783 and has examined 355 patent applications in our dataset. With an allowance rate of 78.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner SHAH, NILAY J's allowance rate of 78.3% places them in the 46% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by SHAH, NILAY J receive 2.28 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SHAH, NILAY J is 37 months. This places the examiner in the 34% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +46.8% benefit to allowance rate for applications examined by SHAH, NILAY J. This interview benefit is in the 91% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.3% of applications are subsequently allowed. This success rate is in the 51% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 38.2% of cases where such amendments are filed. This entry rate is in the 58% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 83.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 65% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 65.2% of appeals filed. This is in the 46% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 42.1% are granted (fully or in part). This grant rate is in the 34% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.2% of allowed cases (in the 69% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.